Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026

Rhea-AI Summary

Evolent Health (NYSE: EVH) will release its 2025 fourth quarter and year-end financial results on Tuesday, February 24, 2026 after market close, followed by a conference call at 5:00 p.m. ET. Participants can listen via the company's investor relations website and analysts may dial in to ask questions. An audio playback will be available on the investor site for 90 days after the call.

Key Figures

Earnings release date: February 24, 2026 Conference call time: 5 p.m. ET Replay availability: 90 days +2 more

5 metrics

Earnings release date February 24, 2026 Q4 and full-year 2025 financial results release after market close

Conference call time 5 p.m. ET Start time for Q4 and year-end 2025 earnings call

Replay availability 90 days Length of time audio playback will be on investor relations website

Domestic dial-in 855.940.9467 Analyst access number for live Q4 2025 earnings call

International dial-in 412.317.6034 International access number for live Q4 2025 earnings call

Market Reality Check

Price: $3.09 Vol: Volume 2,522,342 is 0.8x ...

normal vol

$3.09 Last Close

Volume Volume 2,522,342 is 0.8x the 20-day average of 3,133,968. normal

Technical Price $3.09 is trading below the 200-day MA at $7.56 and near the 52-week low of $3.04 (vs. high $12.07).

Peers on Argus

EVH fell 5.21% with several health information peers also down: OMCL -5.52%, TDO...

EVH fell 5.21% with several health information peers also down: OMCL -5.52%, TDOC -4.49%, HSTM -4.52%, SDGR -5.24%, suggesting broader weakness even though momentum scanners did not flag a coordinated sector move.

Historical Context

5 past events · Latest: Jan 02 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 02	Inducement equity grant	Positive	+1.5%	CFO inducement RSU award of 587,500 shares vesting over three years.
Nov 06	Strategic partnership	Positive	-5.5%	National cancer care model partnership with American Oncology Network.
Nov 06	Earnings results	Positive	-5.5%	Q3 2025 results with higher 2025 revenue and EBITDA guidance.
Oct 09	Earnings date	Neutral	+1.5%	Announcement of Q3 2025 reporting date and related conference call.
Sep 23	Business divestiture	Positive	-2.3%	Sale of Evolent Care Partners for up to $113M and debt prepayment plan.

Pattern Detected

Recent positive or strategic announcements often saw negative price reactions, while neutral scheduling or governance items sometimes coincided with modest gains.

Recent Company History

Over the last few months, Evolent has reported strategic and financial milestones, including the divestiture of Evolent Care Partners for up to $113M on Sep 23, 2025 and Q3 2025 revenue of $479.5M on Nov 6, 2025 with updated 2025 guidance of $1.87B–$1.88B in revenue and adjusted EBITDA of $144M–$154M. Despite these developments, the stock often moved lower after earnings and strategic updates. Today’s earnings-date announcement for Q4 and year-end 2025 fits into this ongoing cadence of scheduled financial communications.

Market Pulse Summary

This announcement schedules the release of Evolent’s Q4 and full-year 2025 results for February 24, ...

Analysis

This announcement schedules the release of Evolent’s Q4 and full-year 2025 results for February 24, 2026, maintaining a consistent communication cadence after market close with a 5 p.m. ET conference call. Recent history includes a major divestiture for up to $113M and Q3 2025 revenue of $479.5M with full-year guidance of $1.87B–$1.88B. Investors may focus on how the new CFO’s tenure, recent board changes, and prior guidance translate into final 2025 performance and 2026 outlook.

Key Terms

nyse

1 terms

nyse financial

"Evolent Health, Inc. (NYSE: EVH), a company focused on achieving..."

A large, regulated marketplace where stocks and other securities are listed and traded, acting like a global auction house that matches buyers and sellers and helps determine share prices. It matters to investors because listing and trading there provide liquidity, price discovery, and regulatory oversight—making it easier to buy or sell holdings and giving companies a visible platform that can affect credibility and access to capital.

AI-generated analysis. Not financial advice.

WASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its 2025 fourth quarter and year-end financial results on Tuesday, February 24, 2026, after market close, with a conference call to follow at 5 p.m. ET.

Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.

Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.

An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.

About Evolent

Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com.

Contacts:
investorrelations@evolent.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-to-release-2025-fourth-quarter-and-year-end-financial-results-on-tuesday-february-24-2026-302679183.html

SOURCE Evolent Health, Inc.

FAQ

When will Evolent (EVH) release its 2025 fourth quarter and year-end results?

Evolent will release 2025 Q4 and year-end results on February 24, 2026 after market close. According to the company, the release is scheduled for after market close with a follow-up conference call at 5:00 p.m. ET the same day.

How can investors listen to Evolent (EVH) earnings conference call on February 24, 2026?

Investors can listen to the live conference call via Evolent's investor relations website webcast. According to the company, the webcast link will be available on the investor site and a live broadcast will stream at 5:00 p.m. ET following the results release.

How can analysts ask questions during the Evolent (EVH) February 24, 2026 conference call?

Analysts should dial the provided phone numbers and reference the 'Evolent call' 15 minutes before the call. According to the company, domestic dial-in is 855.940.9467 and international callers may use 412.317.6034 to participate live.

Will Evolent (EVH) provide a replay of the February 24, 2026 earnings call and for how long?

An audio playback of the conference call will be available on the investor relations website for 90 days after the call. According to the company, the replay will remain accessible on the investor site for three months following the event.

What time is Evolent's (EVH) conference call on February 24, 2026 and where is the dial-in information?

The conference call will begin at 5:00 p.m. ET on February 24, 2026, after the results release. According to the company, dial-in numbers are 855.940.9467 (U.S.) and 412.317.6034 (international), with instructions to reference the 'Evolent call'.